股票代碼
000661
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise吧能
Business
Pharmaceutical i妹短ndustry
Real-estate developme雜笑nt
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivati都朋on
CSR
Concept of responsibil商討ity
Public welfare
CN
About
Group introduct鐘可ion
Leading teams
Organizational chart
Enterprise culture
Development str草看ategy
Honor qualification
Investment enterpr山可ise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibilit美身y
Public welfare
To stimulate the potential o會兒f life so that life blossomed i費討n the hone
Investor
Periodical report
從話 算銀 Company a笑爸nnouncement 開電 關問 訊信 鐵錯 自房 你但
Interactive platform
CN
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Home
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strateg嗎雜y
Honor qualification
Investment enterpri窗離se
Business
Pharmaceutical ind跳短ustry
Real-estate developmen答地t
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
Total
1,913
announcements
關于監事(shì)辭職及補選監事(shì)的公告
2021-01-26
第九屆董事(shì)會(huì)第三十一次會(huì)議決議公告外北
2021-01-26
關于召開(kāi)2021年第一次臨時(shí)股東大報他會(huì)的通知
2021-01-26
獨立董事(shì)關于關于使用部分暫時(s學計hí)閑置自有資金進(jìn)行非保本去看低風險型現金管理的的獨立意見
2021-01-26
關于部分董事(shì)、高級管理人員減持股份預披露公告
2021-01-12
2020年度業績預告
2021-01-06
關于發(fā)行股份及可轉換債券購買資産并募集配套資金暨關聯交術靜易之募集配套資金新增股份解除限售的提示性公告
2021-01-05
中信建投證券股份有限公司、中天國(guó)富證人那券有限公司關于公司發(fā)行股份及可轉換債券購買明習資産并募集配套資金暨關聯交易之募集配套資金新增股份解除限售的核查意見
2021-01-05
關于第一大股東部分股份質押的公告
2020-12-30
關于注銷募集資金專項賬戶的公告
2020-12-25
關于控股子公司金妥利珠單抗注射商亮液獲得美國(guó)FDA藥物臨床試驗批準的公告
2020-12-19
關于持股5%以上股東減持股份超過(guò)1%的公告
2020-12-17
關于發(fā)行股份及可轉換債券購買資産之新增股份部分解除限售的提示性公告
2020-12-15
中信建投證券股份有限公司、中天國(guó)富證券有限公司關于公司發(fā)遠件行股份及可轉換債券購買資産并募集配套資金照村暨關聯交易之部分限售股份上市流通的核查意見
2020-12-15
關于子公司取得成(chéng)都船數(dōu)信立泰重組人促卵泡激素-CTP融合蛋白好街注射液相關權益的公告
2020-12-12
上一頁
25
26
27
28
29
30
31
32
33
34
35
下一頁